Regulators Led Bid To Strengthen ICH Q9 Quality Risk Management

 
• By Joanne S. Eglovitch

Inconsistency among pharmaceutical quality risk assessments drove regulatory authorities' surprise insistence on revising the ICH's 15-year-old Q9 guideline.  

PS1912_Risk_199186658_1200.jpg
Pharmaceutical Official Tells What To Expect In ICH Q9 Revision • Source: Shutterstock

More from Manufacturing

More from Compliance